Top 10 Medical VC Funds & Investors in Hungary (June 2026)

Portfolio highlights

• iBar Experience Kft. — iBar provides an AI  inventory app that integrates into restaurant management software. They offer products and services for pizzerias, bars, discos, hotels, and restaurants.
• SURVIOT Monitoring Kft. — SURVIOT provides smart movement and deformation monitoring solution for civil engineering projects such as bridge, tunnel and dam constructions, quarries, slope stability inspections by monitoring geotechnical and environmental parameters. SURVIOT supports operators and constructors to comply with professional regulations by digitizing labourintensive, manual monitoring processes with automated data collection, processing and analysis. The SURVIOT platform is constantly evolving by adding new sensors and features.
• Linkio - Ecommerce Integration Portal — Integrate wholesalers into your online store easier then ever

Portfolio highlights

• Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
• On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
• NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.

Portfolio highlights

• Flourish Care — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
• Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
• Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.

Portfolio highlights

• Datapao — Discover DATAPAO's data consulting solutions in cloud migrations, data science, data engineering, AI & ML.
• Daytrip — Daytrip is a platform for traveling with local drivers. It allows independent travelers to get the most out of their vacation by connecting them to local drivers, who drive them from one city to another with their own cars, discovering local sights and culture on the way.It gives travelers an opportunity to see otherwise unreachable countrysidesights, meet real locals and get to know local history, culture and current affairs first-hand. Daytrip is an entirely new approach to traveling, combining the comfort of package holidays with the flexibility of independent planning and authenticity of backpacking.
• Hypefy — An influencer marketing platform built for brands that want to discover creators, run campaigns, and measure performance with ease.

Portfolio highlights

• DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
• Xperiome — Match research-ready members to clinical and real-world studies, faster and smarter than ever before through data-driven insights into the rare disease experience.
• AIRMO — Airmo is a space tech company that offers an independent data source that locates, quantifies, and tracks carbon dioxide and methane emissions through a small satellite constellation.

Portfolio highlights

• AERON — ÁERON’S DESIGN IS CHARACTERIZED BY THE UNIQUE COMBINATION OF SUPERB QUALITY, INNOVATIVE CRAFTMANSHIP, AND EFFORTLESS ELEGANCE. EVERY COLLECTION FOCUSES ON REINVENTING TRADITIONAL TAILORING TECHNICS WHILEONLY USING FINEST MATERIALS SUCH AS A DISTINCTIVE SUEDE JAPANESE LEATHER THAT HAS BECOME A SIGNATURE FABRIC OF ÁERON. THE DIFFICULT BALANCE OFCREATING ONE ARTFUL PACKAGE, WHERE WORK AND PLAY HARMONIZES TOGETHER, FORMS THE MINIMAL YET FEMININE SENSUALITY OF A DECADE-DEFINING ÁERON LOOK. ÁERON ENCOMPASSES A RICH VARIETY OF HIGH-WAISTED TAILORED PANTS, ASYMMETRICAL COATS, OVERSIZE SWEATERS, AND MINIMALISTIC DRESSES.
• VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.

Portfolio highlights

• Quino — Quino is an education app for desktop and mobile that generates fun learning games of your uploaded sources.
• Duelbox — Duelbox is a cloud-based entertaining software for events, content creators and broadcasters. For virtual, in-person, or hybrid events, Duelbox has customizable, interactive games to bring people together and boost energy. Shake the show!
• YourAnastomosis — Why are we needed?Until recently, there were no objective methods to evaluate the quality of the practice of vessel anastomosis (vascular suture) for cardiac surgeons, vascular surgeons, and surgical trainees. It was not possible to know how one surgically created vessel suture will behave, and what its long-term effectiveness will be.How arewe solving these challenges?Our technological innovations provide objective feedback about the quality of anastomoses during surgical training. Our method can be used as a convenient and gamified system, for surgical education and training for attendees, learners from all stages of training and levels of expertise. What do we offer?Your Anastomosis offers anastomosis (vascular suture) analysis for surgeons, surgical trainees and medical students. Our technology provides simulated environments, by digitizing and blood flow conditions, and evaluating short and long-term results of the specific vessel. The innovation in our technology allows for an objective assessment of an anastomosis, creating clear surgical and technical suggestions for improvement.

Portfolio highlights

• VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
• Novamigra Therapeutics — Cutting-edge medical care at Agape with Framer template, where AI technology meets compassionate service. Experience personalized treatment and innovative solutions for your health needs.

Portfolio highlights

• Doctor24 — Doktor24 group of companies are able to serve all emerging individual and corporate customer needs in the following areas: allergology, internal medicine, dermatology, dietetics, otolaryngology, cardiology, gynecology, orthopedics, rheumatology, ophthalmology, urology, blood sampling without queuing, imaging diagnostics ( X-rays, ultrasound,mammography), complex health screenings (so-called managerial screening).

Portfolio highlights

• Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
• Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
• PreComb — PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients.